| Autoimmune Neurological Disorders and Treatments | Lifetime | 21 | US 9 | 98.93 |
| Peripheral Neuropathies and Disorders | Lifetime | 77 | US 26 | 99.17 |
| Multiple Sclerosis Research Studies | Lifetime | 154 | US 52 | 98.95 |
| Systemic Lupus Erythematosus Research | Lifetime | 739 | US 248 | 97.88 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 201 | US 98 | 97.48 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 324 | US 151 | 96.23 |
| Long-Term Effects of COVID-19 | Lifetime | 905 | US 203 | 94.50 |
| Myasthenia Gravis and Thymoma | Lifetime | 311 | US 103 | 96.13 |
| Spinal Hematomas and Complications | Lifetime | 159 | US 92 | 94.92 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 383 | US 137 | 95.20 |
| Polyomavirus and related diseases | Lifetime | 690 | US 323 | 95.05 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 1 | US 1 | 99.88 |
| Autoimmune Neurological Disorders and Treatments | 2021-2025 | 1 | US 1 | 99.74 |
| Multiple Sclerosis Research Studies | 2021-2025 | 7 | US 1 | 99.79 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 39 | US 12 | 99.01 |
| Polyomavirus and related diseases | 2021-2025 | 17 | US 2 | 98.44 |
| CNS Lymphoma Diagnosis and Treatment | 2021-2025 | 42 | US 21 | 97.16 |
| Spinal Dysraphism and Malformations | 2021-2025 | 81 | US 38 | 90.80 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 220 | US 80 | 91.99 |
| Bacterial Infections and Vaccines | 2021-2025 | 181 | US 34 | 89.74 |
| Myasthenia Gravis and Thymoma | 2021-2025 | 133 | US 27 | 91.41 |
| Herpesvirus Infections and Treatments | 2021-2025 | 429 | US 139 | 85.93 |
| Genetic Neurodegenerative Diseases | 2021-2025 | 745 | US 174 | 82.53 |
| RNA regulation and disease | 2021-2025 | 606 | US 161 | 75.44 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 511 | US 155 | 80.26 |
| Spinal Hematomas and Complications | 2021-2025 | 245 | US 99 | 71.09 |
| Hereditary Neurological Disorders | 2021-2025 | 457 | US 81 | 70.26 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 770 | US 121 | 45.03 |
| Cerebrovascular and genetic disorders | 2021-2025 | 587 | US 92 | 43.71 |
| Bartonella species infections research | 2021-2025 | 414 | US 82 | 17.04 |
